Exalgo Abuse and Addiction – Latest News
Perrigo will be adding to its portfolio of opioid generics. The FDA has approved Exalgo (hydromorphone HCL, 32 mg) extended-release tablets, another of the company’s generics. The drug is an opioid that is intended to manage moderate to severe pain in patients requiring continuous, around-the-clock pain opioid analgesia for an extended period. Perrigo said that…
Details